Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Amphastar Pharmaceuticals (AMPH) Debt Ratio: 2013-2024

Historic Debt Ratio for Amphastar Pharmaceuticals (AMPH) over the last 12 years, with Dec 2024 value amounting to 0.38.

  • Amphastar Pharmaceuticals' Debt Ratio fell 5.27% to 0.37 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.37, marking a year-over-year decrease of 5.27%. This contributed to the annual value of 0.38 for FY2024, which is 2.17% down from last year.
  • As of FY2024, Amphastar Pharmaceuticals' Debt Ratio stood at 0.38, which was down 2.17% from 0.39 recorded in FY2023.
  • In the past 5 years, Amphastar Pharmaceuticals' Debt Ratio ranged from a high of 0.39 in FY2023 and a low of 0.07 during FY2020.
  • For the 3-year period, Amphastar Pharmaceuticals' Debt Ratio averaged around 0.29, with its median value being 0.38 (2024).
  • In the last 5 years, Amphastar Pharmaceuticals' Debt Ratio decreased by 10.78% in 2022 and then soared by 281.32% in 2023.
  • Amphastar Pharmaceuticals' Debt Ratio (MRY) stood at 0.07 in 2020, then skyrocketed by 55.78% to 0.11 in 2021, then dropped by 10.78% to 0.10 in 2022, then soared by 281.32% to 0.39 in 2023, then dropped by 2.17% to 0.38 in 2024.
  • Its Debt Ratio stands at 0.38 for FY2024, versus 0.39 for FY2023 and 0.10 for FY2022.